Belluscura
  • About Us
    • Board of Directors
    • Executive Management
    • Business Focus
  • Products
  • News
    • Belluscura News
    • Trending Topics
  • Investors
  • Contact
  • Search
  • Menu Menu
  • Facebook
  • Twitter
  • LinkedIn

Belluscura News

Stay current on the latest news and press mentions from Belluscura

Belluscura News

Stay current on the latest news and press mentions from Belluscura

X-PLO₂R™ Portable Oxygen Concentrator Receives FDA Clearance

March 8, 2021/2 Comments/in Belluscura News /by Belluscura

Belluscura is excited to announce that the X-PLO2R™ portable oxygen concentrator has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). We are extremely proud to bring this technology to the market, in doing our part to help improve the quality of life for millions of people worldwide who suffer from chronic […]

Read more
https://www.belluscura.com/wp-content/uploads/2021/03/GetImage.png 788 940 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2021-03-08 07:25:012021-03-08 10:01:45X-PLO₂R™ Portable Oxygen Concentrator Receives FDA Clearance

Respiratory Therapist Spotlight: Ruthie Marker MSRC, RRT

October 26, 2020/in Belluscura News /by Belluscura

Each year, Respiratory Therapists (RT) are celebrated during Respiratory Care Week, happening this year from October 25th to October 31st. RT’s play a vital role in the lives of various patient populations, and most notably this year, providing hands-on care for patients whose breathing has been compromised by the SARS-CoV-2 (COVID-19 Virus) pandemic. Ruthie Marker MSRC, RRT, Manager […]

Read more
https://www.belluscura.com/wp-content/uploads/2020/10/IMG-6285.jpeg 2448 1868 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2020-10-26 16:08:372020-11-30 23:04:02Respiratory Therapist Spotlight: Ruthie Marker MSRC, RRT

New FDA Guidance Provides a Policy Designed to Expand the Availability of Respiratory Devices, Including Oxygen Concentrators, During the COVID-19 Pandemic

March 22, 2020/in Belluscura News /by Belluscura

Today, the U.S. Food and Drug Administration (FDA) issued this immediately in effect guidance: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease-2019 (COVID-19) Public Health Emergency.   The FDA believes the policy set forth in this guidance may help address urgent public health concerns by helping to expand the availability […]

Read more
https://www.belluscura.com/wp-content/uploads/2020/03/200828-fda-editorial.jpg 683 1024 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2020-03-22 20:24:582020-10-07 20:03:49New FDA Guidance Provides a Policy Designed to Expand the Availability of Respiratory Devices, Including Oxygen Concentrators, During the COVID-19 Pandemic

Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation system

March 14, 2020/in Belluscura News /by Belluscura

LONDON, UK, PLANO, TX AND WAYNESBURG, PA, March 13, 2020.  Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel modular portable oxygen enrichment ventilation systems for treating patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS) brought […]

Read more
https://www.belluscura.com/wp-content/uploads/2020/10/shutterstock_1021251352-scaled.jpg 1391 2560 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2020-03-14 01:25:052020-10-07 15:32:42Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation system

Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus

February 6, 2020/in Belluscura News /by Belluscura

LONDON, UK AND PLANO, TX, February 6, 2020.  Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems for treating patients suffering from acute respiratory distress syndrome (ARDS). The latest patent application covers devices and […]

Read more
https://www.belluscura.com/wp-content/uploads/2020/02/0a1-11.jpg 562 1000 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2020-02-06 19:48:322020-10-07 15:34:00Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus

Belluscura PLC raises $2.7 million in latest financing round

August 2, 2019/in Belluscura News /by Belluscura

LONDON, UK AND PLANO, TX, August 2, 2019.  Belluscura PLC announces the successful close of its latest fundraising round. Raising $2.7m, the private placing was priced at US$0.185 (15p) per share, giving Belluscura a post-money valuation of approximately US$9.0m. Beginning with an over-subscribed UK crowdfunding campaign on CrowdCube earlier this year, 12 existing shareholders and […]

Read more
https://www.belluscura.com/wp-content/uploads/2019/08/unnamed.jpg 256 512 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2019-08-02 10:46:522020-11-04 10:44:34Belluscura PLC raises $2.7 million in latest financing round

BELLUSCURA’S CROWDFUNDING CAMPAIGN ON CROWDCUBE IS OVERFUNDED

April 23, 2019/in Belluscura News /by Belluscura

LONDON, UK AND PLANO, TX  April 23, 2019.  Belluscura PLC is excited to announce that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (https://www.crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company. This raise will enable Belluscura to […]

Read more
https://www.belluscura.com/wp-content/uploads/2019/04/images-1.jpg 183 275 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2019-04-23 12:43:362020-10-07 15:59:26BELLUSCURA’S CROWDFUNDING CAMPAIGN ON CROWDCUBE IS OVERFUNDED

Belluscura reaches 91% of target on Crowdcube

April 18, 2019/in Belluscura News /by Belluscura

A substantial new investment has brought our Crowdcube crowdfunding effort to 91% of our funding goal! We are thrilled and humbled to be supported by all the people who, like us, want to improve the lives of millions suffering from chronic lung diseases.

Read more
https://www.belluscura.com/wp-content/uploads/2019/04/136825_00_2x.jpg 790 1184 Belluscura https://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.png Belluscura2019-04-18 08:43:522020-10-07 16:00:04Belluscura reaches 91% of target on Crowdcube
Page 1 of 512345

Belluscura News

  • X-PLO₂R™ Portable Oxygen Concentrator Receives FDA ClearanceMarch 8, 2021 - 7:25 am
  • Respiratory Therapist Spotlight: Ruthie Marker MSRC, RRTOctober 26, 2020 - 4:08 pm
  • New FDA Guidance Provides a Policy Designed to Expand the Availability of Respiratory Devices, Including Oxygen Concentrators, During the COVID-19 PandemicMarch 22, 2020 - 8:24 pm
  • Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation systemMarch 14, 2020 - 1:25 am
  • Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent CoronavirusFebruary 6, 2020 - 7:48 pm

Trending Topics

  • pulmonary rehabilitationUnderstanding Pulmonary RehabilitationMarch 18, 2021 - 8:00 am
  • vaccineCOVID-19 and The Vaccine: 6 Things You Should KnowMarch 3, 2021 - 8:00 am
  • Air Pollution and Your Respiratory HealthFebruary 17, 2021 - 10:50 am
  • wise healthcareHow to Be a Wise Healthcare ConsumerFebruary 5, 2021 - 10:22 am
  • Lungs and the Respiratory SystemJanuary 27, 2021 - 8:43 am
© Copyright 2021 - Belluscura
  • Facebook
  • Twitter
  • LinkedIn
  • Accessibility
  • Privacy Policy
  • Terms & Conditions
  • Compliance
Scroll to top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy